Skip to content

The effectiveness of individual schema therapy in older adults with borderline personality disorder: a multiple-baseline study

The effectiveness of individual schema therapy in older adults with borderline personality disorder: a multiple-baseline study - Schema therapy in older adults with borderline personality disorder

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON46456
Enrollment
10
Registered
2018-06-25
Start date
2018-08-01
Completion date
Unknown
Last updated
2024-04-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

borderline borderline personality disorder

Interventions

Sponsors

Universiteit van Tilburg
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1) a primary diagnosis of BPD, assessed with the Structured Clinical Interview for DSM-5 Personality disorders 2) increased scores on the traits negative affectivity, disinhibition, and psychoticism of the Personality Inventory for DSM-5 3) absence of chronic somatic comorbidity which seriously affects daily life functioning 4) minimum age of 60 years 5) willingness to participate in the study.

Exclusion criteria

Exclusion criteria: 1) Severe depression 2) Bipolar disorder 3) Psychotic disorder (other than transient stress-related psychosis, if this overlaps with criterion 9 of BPD) 4) IQ under 80 5) Substance dependence that needs clinical detoxification 6) Neurocognitive disorder expressed by a MMSE-score below 25

Design outcomes

Primary

MeasureTime frame
The primary outcome measure is the credibility of personal, negative core beliefs, which are measured weekly.

Secondary

MeasureTime frame
Secondary outcome measures are quality of life, psychological distress, early maladaptive schemas, schema modes, severity of BPD symptoms and meeting the criteria for BPD.

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)